Brazil’s leading business magazine, EXAME, recently released their annual 1000 Best and Biggest Companies list, which highlights the strongest performing companies in the country. Zoetis is featured for the fourth year running, with improved rankings from previous years. Zoetis is the only animal health company in the pharmaceutical segment of the list to rank among the top 15.
Zoetis raised £20,000 for the nonprofit organization Hounds for Heroes with its ‘Pounds for Hounds’ fundraising campaign.
Zoetis has joined an exciting new initiative working to advance the standards of small animal veterinary care across Africa.
Zoetis recently unveiled new research that will help pork producers and meat packers produce wholesome pork with less environmental impact.
Targeting the global poultry industry's more than $3 billion in annual losses to coccidiosis, Zoetis introduced Rotecc™ Coccidiosis Management on January 28
In January, Zoetis launched the first and only Janus Kinase (JAK) inhibitor for veterinary use in the United States and Europe.
Zoetis is proud to be the sole animal health company participant in PROHEALTH, a consortium of 22 research partners from 11 European countries coordinated by Newcastle University.
On November 5, Zoetis broke ground on a new manufacturing facility in Suzhou, China.
Zoetis recognizes that heroes come in many shapes and sizes – sometimes even on four legs.
The Zoetis joint venture in Jilin, China announced on August 27 the launch of Rui Lan An™, a specialized vaccine to help control porcine reproductive and respiratory syndrome (PRRS).
Whether it is sending a client a text appointment reminder, ordering medications online using the Zoetis e-Commerce portal or sharing news of interest with clients on Facebook...
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.